DocMorris AG (STU:ZRE) FFO


STU:ZRE DocMorris AG STU:ZRE
68 GF Score
Price €8.96
GF Value €11.36
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is DocMorris AG FFO?

FFO (Funds from operations) only applies to REITs.

STU:ZRE
68GF Score
DocMorris AG STU:ZRE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DocMorris AG (STU:ZRE) Overvalued in 2026?

Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued. The current stock price of €8.96 is trading 21.2% below its estimated GF Value™ of €11.36. GuruFocus considers DocMorris AG to be Modestly Undervalued.

Key valuation signals for STU:ZRE:

  • FFO:
  • GF Value™: €11.36 vs. price of €8.96 (21.2% below fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the STU:ZRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DocMorris AG Business Description

Address Walzmuhlestrasse 49, Frauenfeld, CHE, 8500
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
68GF Score

Get the complete analysis for STU:ZRE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.96
Price
€11.36
GF Value